Navigation Links
Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
Date:7/9/2009

>http://www.rigel.com/rigel/rheumatoid_arthritis.

About Rigel (www.Rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory/autoimmune diseases and metabolic diseases. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

This press release contains "forward-looking" statements, including statements related to the potential efficacy and commercial potential of R788 and Rigel's plans to pursue further clinical development thereof and a corporate partnership. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believe," "plan" and similar expressions are intended to identify these forward-looking statements. There are a number of important factors that could cause Rigel's results to differ materially from those indicated by these forward-looking statements, including risks associated with entering into a corporate partnership agreement and reliance on a corporate partner, the timing and success of clinical trials and the commercialization of product candidates, potential problems that may arise in the clinical testing and approval process and Rigel's need for additional capital, as well as other risks detailed from time to time in Rigel's SEC reports, including its Form 10-Q for the quart
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
4. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
5. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
6. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
7. Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
8. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
9. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
10. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
11. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015   Temptime Corporation ... the health care industry, announced today that its board ... Hooff to chief executive officer.  Mr. Van ... Temptime since 2011. "Renaat deeply values Temptime,s ... outstanding job of expanding Temptime,s products and services to ...
(Date:5/5/2015)... 5, 2015 Silver Creek Pharmaceuticals, Inc. announced ... (SBIR) grant from the National Institute of Health (NIH). ... San Francisco based biotechnology company that discovers ... damaged by disease. This award will be used to ... tissue following a heart attack. Silver Creek,s ...
(Date:5/5/2015)... May 5, 2015 GW Pharmaceuticals plc ... a biopharmaceutical company focused on discovering, developing and ... platform, announced today the closing of the previously ... GW of 1,600,000 American Depositary Shares (ADSs) at ... proceeds of approximately $179.2 million (before deducting underwriting ...
Breaking Medicine Technology:Temptime President Renaat Van den Hooff Promoted to CEO 2Silver Creek Pharmaceuticals Awarded NIH SBIR Grant for Smart Growth Factor Technology 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4
... 2010 Phytomedics, Inc., a transformational healthcare company ... products solely derived from plant sources, announced today ... the amount of $244,000 under the Qualifying Therapeutic ... of its lead product PMI-001 for Rheumatoid Arthritis. ...
... Nov. 9, 2010 NewCardio, Inc. (OTC Bulletin Board: ... announced today that Dr. Samuel George, NewCardio,s Senior Medical ... a blinded "testing" dataset, conducted independently by the Cardiac ... to be held on December 9, 2010, at the ...
Cached Medicine Technology:Phytomedics, Inc. Awarded QTDP Grant from U.S. Department of Health and Human Services 2NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded 'Testing' Dataset 2NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded 'Testing' Dataset 3NewCardio to Present Results of QTinno Performance on Cardiac Safety Research Consortium Blinded 'Testing' Dataset 4
(Date:5/5/2015)... The global lab automation market is ... Million in 2014, at an estimated CAGR of 6.7% ... automation market on the basis of equipment and software, ... the basis of application, Lab Automation Market is classified ... solutions. Drug discovery is a major application of the ...
(Date:5/5/2015)... TX (PRWEB) May 05, 2015 ... selected C.R. Bard Inc., a leading multinational developer, ... in the fields of vascular, urology, oncology and ... 2015 Vanguard Award. The Vanguard Award recognizes ... employee wellness programs among Viverae’s significant client base. ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Dr. Patricia ... pulmonary hypertension (PH). A pulmonologist and pulmonary hypertension specialist ... was attending a work event when an initial idea ... “I was sitting in the audience at the 2010 ... team of healthcare providers – were recalling their climb ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 In a April ... The Herald-Times , the Missouri State Highway Patrol (MSHP) ... Methamphetamine production or use for the second year in a ... to the FBI, reported 1,469 incidents in 2014 alone, around ... only around 2% of the US Population calls Indiana home, ...
(Date:5/5/2015)... 05, 2015 ProTexting, LLC – ... to deploy Mobile Engagement Campaigns and other Mobile solutions, ... clients can now leverage the power of Mobile Marketing ... syncing subscribers’ e-mail addresses into the Constant Contact Platform. ... that the growing trend of multi-channel marketing would become ...
Breaking Medicine News(10 mins):Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3
... Parents offered genetic testing to predict their risks of ... children. That is the finding of a new study ... online April 18). The study authors note these and ... chose predictive genetic tests for themselves and for their children, ...
... the first time, scientists have made star-shaped, biodegradable polymers ... the spheres are injected with cells into wounds, these ... new tissue. Developing this nanofiber sphere as ... of the cell is a very significant advance in ...
... Steven Reinberg HealthDay Reporter , FRIDAY, April 15 ... lies may be showing early signs of dementia, researchers from ... may help doctors diagnose which type of dementia a patient ... "The different dementia patients tended to have difficulty identifying ...
... Meat and poultry sold in the United States is widely ... bacteria that can cause serious illnesses in humans, a new ... to S. aureus range from mild skin infections ... In the new nationwide study, researchers analyzed 136 samples ...
... HealthDay Reporter , FRIDAY, April 15 (HealthDay News) -- Is ... in the Journal of the American Medical Association , ... suggested the latter when it found a reduced risk of ... therapy. This seemed to contradict years of cautions ...
... 15, 2011) Strains of genital herpes in Africa ... States, researchers at Harvard Medical School report, a striking ... preventing HIV transmission in a region staggered by the ... testing mouse model strains of the disease against vaccine ...
Cached Medicine News:Health News:Study: Parents likely to embrace predictive genetic testing for their children if offered 2Health News:Study: Parents likely to embrace predictive genetic testing for their children if offered 3Health News:Researchers inject nanofiber spheres carrying cells into wounds to grow tissue 2Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 2Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 3Health News:Drug-Resistant Staph Bacteria Found in Meat, Poultry Nationwide 2Health News:Drug-Resistant Staph Bacteria Found in Meat, Poultry Nationwide 3Health News:Estrogen's Role in Breast Cancer Can Fluctuate 2Health News:Estrogen's Role in Breast Cancer Can Fluctuate 3Health News:Genital herpes more virulent in Africa than in US 2Health News:Genital herpes more virulent in Africa than in US 3
... This unique system uses prolene as thread-guide ... The hollow Ritleng Probe is inserted into the ... fed through it. The probe is then withdrawn ... mm 0.64 mm diam silicone tubing into place. ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... Ultra-thin collarette conforms to natural anatomy ... Pre-loaded on disposable inserter/dilator instrument for ease ... Slim Mini and Slim Petite plugs offer ... The Slim plugs are made of the ...
For use with Crawford Intubation Systems....
Medicine Products: